Aprea Therapeutics, Inc. (APRE)

Net Income Growth

11.14%

TTM · Period ending:

APRE logo

APRE Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported11.14%
APRE TTM Net Income YoY % (-172.36% → 11.14%)
High-resolution chart · PNG

APRE net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
11.1395%
15.1013%
2.7714%
3.468%
-7.1333%
-10.7284%
9.2956%
-1.6674%
8.3507%
88.3443%
87.3189%
88.7386%
88.5693%
-208.2483%
-203.4479%
-163.5451%
-159.0839%
34.1451%
30.5757%
12.499%
-5.6333%
-58.1507%
-90.5887%
-160.1296%
-172.3574%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.